Johnson & Johnson (NYSE:JNJ) is suing Samsung Bioepis for breach of contract related to the launch of a biosimilar of J&J's ...

More than 20 civil service employees resigned Tuesday from Elon Musk's Department of Government Efficiency, saying they refused to use their technical expertise to "dismantle critical public services.

Three ustekinumab biosimilars enter the US market, expanding access to more affordable options referencing Stelara ...

The BrainSense Adaptive technology is an enhancement to Medtronic’s Percept DBS neurostimulators. The advancement ...

The Phase II trial comes as the US Food and Drug Administration grants an investigational new drug application for cannabis ...

Ketamine, a dissociative anesthetic, has carved itself a spot in the world of mental health care over the past two decades.

We recently published a list of the 10 Best Performing Pharma Stocks So Far in 2025. In this article, we are going to take a ...

We recently published a list of the 10 Oversold Pharma Stocks to Buy According to Analysts. In this article, we are going to ...

Federal regulators say shortages of Ozempic and Wegovy have been resolved, as supplies of popular diabetes and obesity ...

Teva and Alvotech are introducing Selarsdi at an 85% discount off the reference product Stelara. Selarsdi is available as a subcutaneous injection and for intravenous infusion.

Medtech giants are doubling down on robotic surgery systems as hospitals see fewer complications and shorter stays.

Two Omaha women lost more than 300 lbs. combined with injections of a GLP-1 drug, which are used increasingly for weight loss ...